The Market Access and Health Economics team at Putnam PHMR specializes in guiding pharmaceutical and life science companies through the complexities of pricing, reimbursement, and market access strategies. Leveraging expertise in health economics, outcomes research, and health technology assessments (HTAs), the team conducts comprehensive analyses to demonstrate the value of innovative therapies, ensuring clients effectively communicate their benefits to payers and stakeholders. Through meticulous data analysis and strategic insights, they empower clients to navigate the healthcare landscape, optimize pricing models, and enhance patient access to life-changing treatments.
View all